PatientsVille.com Logo

DIABETES MELLITUS and Viagra

PatientsVille

DIABETES MELLITUS Symptoms and Causes

Diabetes is a disease in which your blood glucose, or blood sugar, levels are too high. Glucose comes from the foods you eat. Insulin is a hormone that helps the glucose get into your cells to give them energy. With type 1 diabetes, your body does not make insulin. With type 2 diabetes, the more common type, your body does not make or use insulin well. Without enough insulin, the glucose stays in your blood. You can also have prediabetes. This means that your blood sugar is higher than normal but not high enough to be called diabetes. Having prediabetes puts you at a higher risk of getting type 2 diabetes.

Over time, having too much glucose in your blood can cause serious problems. It can damage your eyes, kidneys, and nerves. Diabetes can also cause heart disease, stroke and even the need to remove a limb. Pregnant women can also get diabetes, called gestational diabetes.

Blood tests can show if you have diabetes. One type of test, the A1C, can also check on how you are managing your diabetes. Exercise, weight control and sticking to your meal plan can help control your diabetes. You should also monitor your blood glucose level and take medicine if prescribed.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for DIABETES MELLITUS

DIABETES MELLITUS treatment research studies

Viagra clinical trials, surveys and public health registries


Find Drug Side Effect reports



Viagra Side Effects

Headache (505)
Erection Increased (390)
Flushing (324)
Optic Ischaemic Neuropathy (314)
Erectile Dysfunction (300)
Vision Blurred (278)
Hypertension (219)
Dizziness (211)
Prostate Cancer (194)
Visual Acuity Reduced (189)
Nasal Congestion (184)
Incorrect Dose Administered (178)
Blood Cholesterol Increased (173)
Penis Disorder (172)
Death (168)
Myocardial Infarction (165)
Cyanopsia (160)
Dyspnoea (145)
Feeling Abnormal (141)
Cerebrovascular Accident (134)
Blood Pressure Increased (95)
Chest Pain (93)
Visual Field Defect (92)
Diabetes Mellitus (92)
Malaise (83)
Nausea (80)
Pain (78)
Penile Pain (77)
Cataract (75)
Loss Of Consciousness (73)
Heart Rate Increased (72)
Depression (71)
Tinnitus (70)
Condition Aggravated (69)
Off Label Use (68)
Feeling Hot (68)
Visual Impairment (67)
Abdominal Discomfort (66)
Anxiety (66)
Visual Disturbance (65)
Erythema (64)
Dyspepsia (64)
Fall (62)
Ejaculation Disorder (60)
Fatigue (60)
Coronary Artery Occlusion (58)
Weight Decreased (54)
Deafness (54)
Blood Testosterone Decreased (53)
Hypotension (53)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Blepharospasm.

I received an injection of zostavax in August 2005 and approx 3 months later I was diagnosed with TYPE 1 DIABETES. No one in my entire family history has ever had diabetes. I was and still am 185 lbs.

Hello, I was given Azastin or Avastin for macular edema. I also have retinopathy from diabetes. I was given this shot in my eye in April of this yr. Within 2 days, I had cellulitis in both legs. Horrible pain. Dark red all over from my knees to my

Another thing, can a patient with diabetes type 1 and previously suffered and recovered from Multiple sclerosis ( M-S ) use Spasfon ???

Before I took atenolol i had a perfect glucose numbers after taking it I came down with diabetes. I am 102lbs, 4'11, have always eaten healthy, exercise my whole life. I am 76. I was taken off atenolol after5 years...and NO ONE in my family for ge

Burning sensation, confusion, mental states changes, lethargy, chest pain, pain, communication difficulty.88 years old with astma, high blood pressure, diabetes, prostate enlargement,

Can I take ciprofloxacin with my medicines for diabetes

Can taking of Neuleptil unregularely by father couse a 1st level diabetes for his son?

Dont get discouraged, I am 21 years old and got diagnosed with diabetes when i was 15. I hated it for a little while then i thought well i have to live with it so i better make the best of it. I, just like anyone, wanted to live an ordinary teen life

Good effects on diabetes. weight reduction -rapid and moderate to excessive hair fall after 3 months of use

Hi, I'm 21 years old, recently released from the hospital for possible brain infection (took a variety of antibiotics and anti-virals). I have possible diabetes and I recently developed tinnitus I think, and the possible causes for it is my prolonged

I am 14 and type one diabetic, and i just want it to go away so i can live a normal happy life, i would like to drink to see what its like (typical teen) but i really dont want diabetes , so i don't really care about it, my mum and dad get worried be

DIABETES MELLITUS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?
Condition: Pulmonary Hypertension
Interventions: Drug: Sildenafil (Viagra);   Drug: Sildenafil;   Drug: Placebo
Outcome Measures: To determine the efficacy of 12.5mg oral sildenafil to decrease the mPAP in patients presenting with a mPAP >/= 25mmHg after cardiopulmonary bypass.;   To determine the efficacy of a second dose of oral sildenafil 12.5mg to decrease the mPAP in those patients who do not respond with a 20% decrease in mPAP after the initial administration of study medication.;   To determine the safety of oral sildenafil to treat increased mPAP after cardiac surgery.
2 Unknown  Sildenafil for Prevention of Cerebral Vasospasm
Conditions: Subarachnoid Hemorrhage;   Cerebral Vasospasm;   Rupture of Intracranial Aneurysm
Interventions: Drug: Placebo;   Drug: Sildenafil Citrate, 25 mg, 3 times a day.;   Drug: Sildenafil Citrate 50 mg, 3 times a day
Outcome Measures: New neurological Deficit;   Transcranial Ecodoppler;   Mortality;   Side effects;   Time to discharge;   Rankin Scale
3 Unknown  A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil Citrate 20mg Tablet Sublingual;   Drug: Viagra ® 50mg tablet Coated
Outcome Measures: Evaluate a possible superiority expressed by the faster onset of action.;   Evaluate the efficacy and tolerability of Sildenafil Citrate 20mg Sublingual tablet, compared to Viagra ® 50mg tablet Coated in control of Erectile Dysfunction.
4 Recruiting Pharmacokinetics of Sildenafil in Premature Infants
Condition: Persistent Pulmonary Hypertension of the Newborn
Intervention: Drug: 1 dose of sildenafil
Outcome Measures: Area under the plasma concentration versus time curve 0-24 hours for sildenafil;   Peak plasma concentration of sildenafil;   Clearance of sildenafil;   Volume of distribution at steady state;   Half life of sildenafil;   Number of subjects with adverse events as a measure of safety and tolerability.;   Correlation between serum and dried blood spot samples;   Evaluate P450 single nucleotide polymorphisms (SNPs)
5 Unknown  Use of Sildenafil (Viagra) to Alter Fatigue, Functional Status and Impaired Cerebral Blood Flow in Patients With CFS
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Sildenafil (Viagra);   Drug: Placebo
Outcome Measure: The principal aim of this study is to determine whether chronic fatigue syndrome (CFS) is due to inadequate blood flow to the brain and to test a medication, Viagra, which should help increase blood flow to the brain and improve the symptoms of CFS.
6 Unknown  Effects of Viagra on Heart Function in Patients With Heart Failure
Conditions: Heart Failure;   Left Ventricular Dysfunction
Intervention: Drug: sildenafil
Outcome Measures: The primary outcome measure is a fall in the left ventricular filling pressure in association with administration of sildenafil;   A secondary outcome is the distance walked with the 6-minute walk test after the administration of sildenafil
7 Not yet recruiting Effects of Oral Sildenafil on Mortality in Adults With PAH
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil citrate
Outcome Measures: Overall Survival (OS);   Time to first clinical worsening (TTCW) event;   6 Minute Walk Distance (6MWD) at Months 6 & 12
8 Recruiting VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
Condition: Pulmonary Hypertension Associated With Connective Tissue Disease
Intervention: Drug: Sildenafil
Outcome Measures: efficacy of Sildenafil I.V. for vasoreactivity testing;   clinical efficacy of sildenafil per os predicted by testing it intravenously in the course of oral therapy
9 Unknown  Early Start of Oral Sildenafil 100mg for Erectile Dysfunction After Robotic Assisted Laparoscopic Radical Prostatectomy
Condition: Prostate Cancer
Intervention: Drug: sildenafil 100mg
Outcome Measures: patterns of recovery of erectile functions after nerve sparing RALP in men with on- demand sildenafil 100mg dosing from the early postoperative period (using IIEF-5);   comparison of the potency rates in men with on- demand sildenafil 100mg dosing from the early postoperative period with from the delayed postoperative period
10 Unknown  Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure
Condition: Heart Failure
Intervention: Drug: Sildenafil
Outcome Measures: Change in 6-minute walk distance;   Changes in peak oxygen consumption (measured by cardiopulmonary exercise testing);   Change in the level of neurohormones (b-type natriuretic peptide, catecholamines, ET-1),;   Change in quality of life
11 Unknown  The Effects of Sildenafil on Exercise Function and Capacity in Patients With Fontan Circulation
Condition: Fontan Circulation
Interventions: Drug: sildenafil;   Other: placebo
Outcome Measure: An increase in exercise capacity for patients administered sildenafil
12 Recruiting The Revaki-001. A Study to Determine the Pharmacokinetic Profile, Safety and Tolerability of Sildenafil (REVATIO®) in Cardiac Surgery
Condition: Acute Kidney Injury
Intervention: Drug: Sildenafil
Outcome Measures: Area under the plasma concentration versus time curve and Plasma Concentration of Sildenafil;   Serum creatinine and Biochemical markers of AKI
13 Recruiting Effects of Sildenafil on Choroidal Thickness in AMD
Condition: Age-related Macular Degeneration
Intervention: Drug: Sildenafil citrate
Outcome Measures: Change in Choroidal Thickness as Assessed on Enhanced-Depth Imaging Optical Coherence Tomography (EDI-OCT);   Change in Central Foveal Thickness as assessed by optical coherence tomography (OCT)
14 Unknown  Viagra for the Treatment of IUGR
Condition: IUGR
Intervention: Drug: Viagra administration in IUGR/PET pregnancies
Outcome Measures: Uteroplacental perfusion;   Fetal growth;   Maternal and fetal safety
15 Not yet recruiting Blood Flow and Vascular Function in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: Acute (1 hour) Sildenafil;   Drug: Sub-Chronic (4 weeks) Sildenafil;   Drug: Placebo
Outcome Measures: Exercise Capacity;   Flow-Mediated Dilation (FMD);   Arterial Stiffness Evaluation (PWV);   Physio Flow
16 Recruiting "As Required" Oral Sildenafil in Raynaud's Phenomenon
Condition: Raynaud's Phenomenon
Interventions: Drug: Sildenafil 40 mg;   Drug: Sildenafil 80 mg;   Drug: Placebo
Outcome Measures: Mean change in the Raynaud's Condition Score (RCS) during treatment, as compared to placebo.;   Frequency of RP: number of RP attacks during treatment, as compared to placebo.;   Patients' preference: comparison between the number of patients favoring a treatment to another.;   Pain associated with RP: Mean change in the Raynaud's pain score during treatment, as compared to placebo.;   Frequency and severity of adverse drug events during treatment, as compared to placebo;   Microvascular reactivity: index of skin perfusion in response to local/regional cooling after a single dose of sildenafil, as compared to placebo (laboratory experiments)
17 Recruiting Effectiveness of the Vasodilator Test With Revatio, Made in Patients With Acute Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: Sildenafil 20mg oral vs Sildenafil 10mg intravenous
Outcome Measure: Effectiveness
18 Recruiting Sildenafil Citrate Before Surgery in Improving Kidney Function in Patients With Kidney Cancer
Condition: Kidney Tumor
Interventions: Drug: sildenafil citrate;   Other: placebo;   Procedure: therapeutic conventional surgery
Outcome Measures: Accrual rate;   Retention rate;   Participation rate;   Change in GFR;   Change in proteinuria;   Estimated blood loss;   Hemoglobin concentration;   Changes in blood pressure measurements;   Vasopressor support requirements during the operative procedure;   Intravenous fluid requirements during the operative procedure;   Overall complication rates;   Preliminary effect size of sildenafil citrate on change in GFR
19 Unknown  On Demand Versus Daily Sildenafil for Patients Undergoing Radical Prostatectomy
Condition: Erectile Dysfunction
Intervention: Drug: Sildenafil
Outcome Measures: Proportion of patients with an Erectile Function domain score of International Index of Erectile Function ( IIEF) => 22 at the end of the wash-out period (44 wks after surgery);   Proportion of patients with an Erectile Function domain score of IIEF => 22 at the end of the study (52 wks after surgery);   IIEF - Domain Scores for: Erection Hardness Score (1-4) Intercourse success rates defined by the Sexual Encounter Profile (SEP) questionnaire (questions 2 and 3) Safety Endpoints: Adverse event summarized Global assessment questions
20 Not yet recruiting Growth Hormone or Sildenafil as Therapies for Fatigue in Mild-​Traumatic-brain-injury (MTBI)
Condition: Traumatic Brain Injury
Interventions: Drug: Growth Hormone;   Drug: Sildenafil;   Drug: Placebo
Outcome Measures: Perceptual fatigue as measured weekly using the Brief Fatigue Inventory;   Performance fatigue as measured by using hand and leg dynamometry.